206 related articles for article (PubMed ID: 33008321)
1. Detection of gray matter microstructural changes in Alzheimer's disease continuum using fiber orientation.
Lee P; Kim HR; Jeong Y;
BMC Neurol; 2020 Oct; 20(1):362. PubMed ID: 33008321
[TBL] [Abstract][Full Text] [Related]
2. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PET.
Silva-Rudberg JA; Salardini E; O'Dell RS; Chen MK; Ra J; Georgelos JK; Morehouse MR; Melino KP; Varma P; Toyonaga T; Nabulsi NB; Huang Y; Carson RE; van Dyck CH; Mecca AP
Am J Geriatr Psychiatry; 2024 Jan; 32(1):17-28. PubMed ID: 37673749
[TBL] [Abstract][Full Text] [Related]
4. Differential microstructural and morphological abnormalities in mild cognitive impairment and Alzheimer's disease: Evidence from cortical and deep gray matter.
Gong NJ; Chan CC; Leung LM; Wong CS; Dibb R; Liu C
Hum Brain Mapp; 2017 May; 38(5):2495-2508. PubMed ID: 28176436
[TBL] [Abstract][Full Text] [Related]
5. White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.
Kantarci K; Schwarz CG; Reid RI; Przybelski SA; Lesnick TG; Zuk SM; Senjem ML; Gunter JL; Lowe V; Machulda MM; Knopman DS; Petersen RC; Jack CR
JAMA Neurol; 2014 Dec; 71(12):1547-54. PubMed ID: 25347157
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Detection of Changes Related to Cortical Columnar Organization and Neuroinflammation Across the AD Continuum.
Torso M; Ridgway GR; Hardingham I; Schwarz AJ; Chance SA
J Prev Alzheimers Dis; 2022; 9(4):769-779. PubMed ID: 36281682
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal changes in microstructural white matter metrics in Alzheimer's disease.
Mayo CD; Mazerolle EL; Ritchie L; Fisk JD; Gawryluk JR;
Neuroimage Clin; 2017; 13():330-338. PubMed ID: 28066707
[TBL] [Abstract][Full Text] [Related]
8. Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
Kim M; Song YS; Han K; Bae YJ; Han JW; Kim KW
J Alzheimers Dis; 2024; 99(1):279-290. PubMed ID: 38669532
[TBL] [Abstract][Full Text] [Related]
9. Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.
Wu L; Rowley J; Mohades S; Leuzy A; Dauar MT; Shin M; Fonov V; Jia J; Gauthier S; Rosa-Neto P;
PLoS One; 2012; 7(10):e47905. PubMed ID: 23112868
[TBL] [Abstract][Full Text] [Related]
10. Diffusion tensor imaging of white matter degeneration in Alzheimer's disease and mild cognitive impairment.
Amlien IK; Fjell AM
Neuroscience; 2014 Sep; 276():206-15. PubMed ID: 24583036
[TBL] [Abstract][Full Text] [Related]
11. Mapping ventricular expansion onto cortical gray matter in older adults.
Madsen SK; Gutman BA; Joshi SH; Toga AW; Jack CR; Weiner MW; Thompson PM;
Neurobiol Aging; 2015 Jan; 36 Suppl 1():S32-41. PubMed ID: 25311280
[TBL] [Abstract][Full Text] [Related]
12. Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease.
Kljajevic V; Grothe MJ; Ewers M; Teipel S;
Neurobiol Aging; 2014 Sep; 35(9):1973-81. PubMed ID: 24811241
[TBL] [Abstract][Full Text] [Related]
13. Gray to white matter signal ratio as a novel biomarker of neurodegeneration in Alzheimer's disease.
Putcha D; Katsumi Y; Brickhouse M; Flaherty R; Salat DH; Touroutoglou A; Dickerson BC
Neuroimage Clin; 2023; 37():103303. PubMed ID: 36586361
[TBL] [Abstract][Full Text] [Related]
14. Cortical microstructural associations with CSF amyloid and pTau.
Nir TM; Villalón-Reina JE; Salminen LE; Haddad E; Zheng H; Thomopoulos SI; Jack CR; Weiner MW; Thompson PM; Jahanshad N;
Mol Psychiatry; 2024 Feb; 29(2):257-268. PubMed ID: 38092890
[TBL] [Abstract][Full Text] [Related]
15. Association between CSF Aβ42 and amyloid negativity in patients with different stage mild cognitive impairment.
He B; Wang L; Xu B; Zhang Y;
Neurosci Lett; 2021 May; 754():135765. PubMed ID: 33667602
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Gray Matter Microstructural Alterations in Alzheimer's Disease by Free Water Imaging.
Nakaya M; Sato N; Matsuda H; Maikusa N; Ota M; Shigemoto Y; Sone D; Yamao T; Kimura Y; Tsukamoto T; Yokoi Y; Sakata M; Abe O
J Alzheimers Dis; 2024; 99(4):1441-1453. PubMed ID: 38759008
[TBL] [Abstract][Full Text] [Related]
17. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
18. Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.
Halawa OA; Gatchel JR; Amariglio RE; Rentz DM; Sperling RA; Johnson KA; Marshall GA;
Alzheimers Res Ther; 2019 Jan; 11(1):14. PubMed ID: 30704519
[TBL] [Abstract][Full Text] [Related]
19. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
[TBL] [Abstract][Full Text] [Related]
20. Morphological and Microstructural Changes of the Hippocampus in Early MCI: A Study Utilizing the Alzheimer's Disease Neuroimaging Initiative Database.
Lee P; Ryoo H; Park J; Jeong Y;
J Clin Neurol; 2017 Apr; 13(2):144-154. PubMed ID: 28176504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
